L. Xiao et al., MOLECULAR-CLONING, EXPRESSION AND CHARACTERIZATION OF CDNA-ENCODING AMOUSE ALPHA(1A)-ADRENOCEPTOR, British Journal of Pharmacology, 124(1), 1998, pp. 213-221
1 In this study, we have cloned, expressed, and characterized an alpha
(1a)-adrenoceptor gene from the mouse. We designed oligonucleotide PCR
primers complementary to regions of the rat alpha(1a)-adrenoceptor se
quence and amplified cDNA fragments from total RNA of mouse cerebral c
ortex, liver and kidney by reverse transcription-polymerase chain reac
tion (RT-PCR). 2 Both the nucleotide and deduced peptide sequences of
the cDNA showed high sequence identity with those of cloned alpha(1a)-
adrenoceptors from other species. The cDNA clone had an open reading f
rame of 1398 nucleotides encoding a 466 amino acid peptide which had 9
7%, 92% and 90% identity with the deduced amino acid sequences of the
rat, human and bovine alpha(1a)-adrenoceptor, respectively. 3 The ampl
ified mouse cDNA was inserted into a mammalian expression vector pcDNA
3.1(+) and expressed in COS-1 cells. The pharmacological properties of
the mouse cDNA clone were examined in radioligand binding studies and
functional assays. The expressed mouse protein had a high affinity fo
r [H-3]-prazosin (K-d = 0.48 nM) and pattern of affinity for antagonis
ts in competition studies that is similar to that of the rat alpha(1a)
-adrenoceptor. Chloroethylclonidine (CEC) could slowly alkylate the ex
pressed protein, with a rate similar to that of the rat alpha(1a)-adre
noceptor. 4 The expressed receptors were able to mediate noradrenaline
(NA) stimulation of the production of inositol phosphates in COS-I ce
lls, consistent with coupling to phospholipase C. This response to NA
could be reversed by pretreatment of the transfected cells with prazos
in. 5 Based on the above evidence, we concluded that the cloned cDNA i
s that of the mouse alpha(1a)-adrenoceptor.